In 2014, we reported a model for donor-recipient (D-R) matching in liver transplantation (LT) based on artificial neural networks (ANNs) from a Spanish multicenter study (Model for Allocation of Donor and Recipient in España [MADR-E]). The aim is to test the ANN-based methodology in a different European health care system in order to validate it. An ANN model was designed using a cohort of patients from King's College Hospital (KCH; n 5 822). The ANN was trained and tested using KCH pairs for both 3-and 12-month survival models. End points were probability of graft survival (correct classification rate [CCR]) and nonsurvival (minimum sensitivity [MS]). The final model is a rule-based system for facilitating the decision about the most appropriate D-R matching. Models designed for KCH had excellent prediction capabilities for both 3 months (CCRarea under the curve [AUC] 5 0.94; MS-AUC 5 0.94) and 12 months (CCR-AUC 5 0.78; MS-AUC 5 0.82), almost 15% higher than the best obtained by other known scores such as Model for End-Stage Liver Disease and balance of risk. Moreover, these results improve the previously reported ones in the multicentric MADR-E database. In conclusion, the use of ANN for D-R matching in LT in other health care systems achieved excellent prediction capabilities supporting the validation of these tools. It should be considered as the most advanced, objective, and useful tool to date for the management of waiting lists.
applicability and excellent outcomes, the number of candidates continues to grow. The number of donors is not enough to satisfy the current demand. As a result, death and dropout from the waiting list continue to be significant. Over the last 20 years, criteria for considering a suitable graft for transplantation have changed and the use of extended criteria donors (ECDs) is widely accepted in the transplant community. However, the balance between waiting list, ECDs, and outcomes after transplantation is fragile, and care is required to maintain outcomes after LT on an intention-to-treat basis. (1) It is well-known that donor and recipient matching (donor-recipient [D-R] matching) is important in determining outcomes after LT and several "scores" have been proposed. (2) (3) (4) The use of high-risk donors in high-risk recipients is a complex combination that is not always advantageous. (5) (6) (7) Similarly, others have analyzed the impact of some factors in some recipients but not for others (ie, donor macrosteatosis and hepatitis C Abbreviations: ALF, acute liver failure; ALT, alanine aminotransferase; ANN, artificial neural network; AST, aspartate transaminase; AUC, area under the curve; AUROC, area under the receiver operating characteristic curve; BAR, balance of risk; BMI, body mass index; CCR, correct classification rate; CIT, cold ischemia time; CMV, cytomegalovirus; CVA, cardiovascular accident; DCD, donation after cardiac death; D-MELD, donor Model for End-Stage Liver Disease; DRI, donor risk index; D-R, donor-recipient; ECD, extended criteria donor; HBcAb, hepatitis B core antibody; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; ICU, intensive care unit; ITU, intensive therapy unit; KCH, King's College Hospital; LT, liver transplantation; MADR-E, Model for the Assignment of Donor and Recipient in España; MELD, Model for End-Stage Liver Disease; MOEA, multiobjective evolutionary algorithm; MPENSGA2, memetic Pareto evolutionary approach based on the NSGA2 evolutionary algorithm; MS,
virus [HCV] versus non-HCV recipients)
. (8) D-R matching is not only important in terms of individual outcomes; it is also of interest when considering the benefit for the overall population. An optimal D-R matching is the key for an allocation system that intends to be objective and equal for every patient. (9) In 2014, the Spanish LT groups reported the utility of a rule-based system based on artificial neural networks (ANNs) as an optimal D-R matching system (Model for the Assignment of Donor and Recipient in España [MADR-E]) for LT in a large multicenter cohort of D-R pairs. (10) In this study, ANNs were superior to all other scores published to date in predicting graft survival and graft loss for the area under the curve (AUC) metric. The manuscript included a model in which it was possible to observe how donor livers were allocated to recipients in both standard and extended criteria groups. The developed system used a well-known multiobjective evolutionary algorithm (MOEA) technique for training an ANN model. Using this strategy, we also constructed a probabilistic rule-based system for D-R matching, using the first 5 recipients on the waiting list according to Model for End-Stage Liver Disease (MELD) score for assigning the graft. In this way, the objectives are to maximize the survival probability for 3 and 12 months and minimize the nonsurvival probability. If the probability for the first recipient is not significant with respect to the rest, the MELD criterion is considered. Therefore, our system combines both the survival and justice principles.
It was suggested that a validation of this methodology would be further needed in order to analyze if the results obtained in MADR-E could be duplicated elsewhere in Europe. The aim of our study is to analyze if our rule-based system has a similar behavior in a different health care system and whether it would be a powerful tool for D-R matching in comparison to other current models.
Patients and Methods

HOSPITAL SELECTION
From the whole spectrum of hospitals in Europe, we performed the external validation with King's College Hospital (KCH) National Health Service Foundation Trust in London, United Kingdom. The reasons for choosing this center were as follows: first, it is one of the highest-volume centers (>200 transplants per year) in Europe with excellent results and protocols; second, data collection seems fairly more strict and homogeneous, and there is less missing data if validation comes from a single unit; and third, KCH belongs to a public health care system (similar to Spain) but with clear differences in terms of donation and allocation policies. All patients included in the current study signed informed consent. The research was approved by the ethics committee of the University Hospital Reina Sofia.
PATIENT SELECTION
KCH Data Set
To obtain a similar number of patterns, only reported pairs from January 2002 to December 2010 were included. Thereby, a data set containing 858 English D-R pairs was collected.
Exclusion Criteria
Pediatric LTs, living donor LTs, and hepatocellular carcinoma (HCC) were the exclusion criteria. These last 2 exclusion criteria were because they follow different allocation policies, not strictly ruled by MELD score or random MELD score with point additions minimum sensitivity; PBC, primary biliary cirrhosis; PSC, primary sclerosing cholangitis; P-SOFT, predict survival outcomes following liver transplantation; ROC, receiver operating characteristic; SD, standard deviation; SOFT, survival outcomes following liver transplantation score; TIPS, transjugular intrahepatic portosystemic shunt.
according to time on the waiting list or high-/low-risk HCC criteria.
MISSING VALUES: IMPUTATION TECHNIQUES
Once the data were collected, it was necessary to perform some classical techniques of data imputation in order to replace all the missing values. To do so, first, when the ratio of missing values for any variable was <1%, those were substituted by the mean (in the case of a continuous and quantitative variable) and by the mode (in the case of a binary and qualitative variable). When the ratio of missing values was >1% and <10%, a linear and nonlinear regression analysis was performed for recovering those missing values. Finally, patterns with a percentage of missing values >10% were not considered for the study. Multiple linear regression models were performed for creatinine, sodium, aspartate transaminase (AST), alanine aminotransferase (ALT), and bilirubin when 1 missing value was detected if all the rest were present. For the imputation of body mass index (BMI), polynomic regressions were performed between weight and height. Multiple linear regressions were also performed for time on waiting list, MELD at inclusion, MELD at the time of the transplant, and Child-Pugh at inclusion, whenever the rest of the variables were fulfilled.
BUILDING THE ANNS: MODELS OF D-R MATCHING
In order to obtain the best knowledge of D-R prognosis, a new system was developed for graft assignment. For each D-R pair, 2 probabilities were calculated using 2 different and noncomplementary models: the positive-survival model and the negative-loss model.
1.
The positive-survival model consists of a neural network, which predicts the probability of 3-month graft survival after LT. This model uses the mathematical concept of correct classification rate (CCR), or accuracy, defined as the percentage of correctly classified training patterns. This model tries to maximize the probability that a D-R pair has of belonging to the "graft survival" class. 2. The negative-loss model consists of a neural network giving the probability of nonsurvival of the graft at 3 months following the transplant. This model uses the mathematical concept of minimum sensitivity (MS), defined as the minimum value of the sensitivities of each of the classes. This model tries to maximize the probability that a D-R pair has of belonging to the "nongraft-survival" class.
BUILDING THE ANNS: THE TRAINING/TESTING PROCESS
The values of the connections and the structure of the models are determined by an evolutionary algorithm.
To verify that the individuals obtained by the evolutionary algorithm are efficient, the coefficients of the individual neural network models are trained with a subset of the database (training set) and tested with the rest of the database (generalization set). (11) Because it is common in the area of artificial intelligence, a 10-fold cross-validation experimental design is used. Briefly, the whole data set is randomly divided, and 90% of the patients are used for the training step, leaving 10% for the final testing. This process is performed 10 times, and in this sense, all patterns are considered in the testing phase. In this article, we analyze the best CCR and MS models. The 2 "best models" are those that correctly classify the highest number of pairs in both categories of graft survival and graft loss.
BUILDING THE ANNS: ALGORITHMS USED
The positive-survival and negative-loss models are ANN models. An ANN is a mathematical model inspired by biological neural networks used to learn and predict the end point variable from a given set of input data (in this case, characteristics of recipients, donors, and other operative factors were considered). The interest in ANN models for predicting outcome after LT dates back to 2 decades ago. (12) In this manuscript, a MOEA was used to train and optimize these ANN models. The weights and structure of the ANNs were adjusted by different operators employed by the MOEA during the evolutionary process. Both the operators and the MOEA are inspired by biological evolution, performing methodologies such as reproduction, mutation, or selection. In our work, the evolutionary process of the MOEA was guided by 2 different competing objective functions. The former function considered was the accuracy or CCR (maximizing the belonging to the survival class) and the latter was the MS (maximizing the belonging to the nonsurvival class), which reports the minimum classification rate per class of all of the classes in the problem. Thus, the CCR metric will be focused on overall classification, whereas MS will focused on the minority class classification (in our cases, nonsurvival class). (13) A memetic Pareto evolutionary approach based on the NSGA2 evolutionary algorithm (MPENSGA2) was selected as MOEA in this article in order to train the ANN models, because it has been shown to achieve competitive performance with a limited computational cost. (13) Once the evolutionary process of the algorithm has been completed, the best models (1 for CCR and 1 for MS) have been selected as potential solutions to the problem.
EXPERIMENTS
In this article, the rule-based system is constructed using data from an European high-volume LT unit (KCH). According to previous suggestions, 3-and 12-month graft survival models were obtained. Note that a new D-R matching classification model is created for KCH because this is the common procedure in artificial intelligence (given that the data characteristics of KCH are similar, but not entirely identical). With this model, the aim is to study whether ANNs work well in a different population within Europe. This implies that the D-R matching model developed using KCH data is not universally applicable for clinicians all around the world, although ANNs are considered as universal approximations and can be successfully used for this purpose. Note that, for the sake of robustness, any multivariate or artificial intelligence models (such as logistic regression (14, 15) or ANNs) should be retrained when a new significant number of data is available. The creation of a supranational model that combines data from multiple transplantation units is desirable, and the proposed ANN-based methodology, as shown in this article, appears adequate for this aim.
THE RULE-BASED SYSTEM
With the 2 models obtained, a rule-based decision support system was designed, with the MELD score as the cornerstone of this model. The ANN will choose 1 D-R pair over the other when the difference of the probability of belonging to the class of graft survival exceeds 3%, because the CCR model presents a standard deviation (SD) value of 2.9%, and when the difference of the probability of belonging to the class of nonsurvival is over 5%, because the MS model presents a SD value of 5.5%. These 2 differences, over 3% for CCR and greater than 5% for MS, allowed the design of this rule-based system. Therefore, in the case of a draw, ie, when the ANN is not capable of determining significant differences, the D-R matching is allocated by MELD.
COMPARISONS AGAINST OTHER SCORES
To test the accuracy of our ANN-based model in predicting both graft and loss, comparisons with other current validated scores were performed using the same KCH data partitions. Receiver operating characteristic (ROC) curves (and the corresponding AUC values) were obtained for every score to predict both end points and compared against CCR and MS models. According to current literature, MELD, (16) donor Model for End-Stage Liver Disease (D-MELD), (17) donor risk index (DRI), (2) predict survival outcomes following liver transplantation (P-SOFT), survival outcomes following liver transplantation score (SOFT), (3) and balance of risk (BAR) (4) scores were calculated. To compare classifiers, it is desirable to reduce ROC performance to a single scalar, and the most common method is to calculate the area under the receiver operating characteristic curve (AUROC), which can be interpreted as the probability that a classifier will assign a higher score to a randomly chosen positive pattern than to a negative one. The best algorithm should produce the dominant curve, which also has the largest AUROC. (18) 
COMPARISON METHODOLOGY
The imbalanced distribution of classes constitutes a difficulty for standard learning algorithms because they are, in general, biased toward majority classes (survival class). As a result, patterns from the majority classes are classified correctly by created classifiers, whereas patterns from the minority class (nonsurvival class) tend to be misclassified. Classification accuracy may lead to erroneous conclusions because the minority class has very little impact on accuracy as compared with the majority class. (19) Therefore, accuracy is not an appropriate performance measure with imbalanced data sets. In this manuscript, we used an alternative metric of accuracy to overcome these difficulties for 2 classes of ANN classification models, the ROC curve. (20, 21) Some classifiers naturally yield probability or score for an instance, a numeric value that represents the degree to which an instance is a member of a class. Such a ranking or scoring classifier can be used with a threshold to produce a binary classifier. Each threshold value produces a different point in ROC space, and if we join all these points we obtain a ROC curve. To compare classifiers, we may want to reduce ROC performance to a single scalar value, and the most common method is to calculate the AUROC, which can be interpreted as the probability that a classifier will assign a higher score to a randomly chosen positive pattern than to a negative one. (22, 23) The best algorithm should produce the dominant curve, which also has the largest AUROC. It has been proven that AUROC is statistically consistent and more discriminating than accuracy. (24) ETHICAL AND HUMANE TREATMENT CONSIDERATIONS Every procedure, including obtaining informed consent, was conducted in accord with the ethical standards of the Helsinki Declaration of 1975.
Results
DESCRIPTIVE ANALYSIS
Considering the surviving/nonsurviving graft classes, there were 739/83 in the KCH database. For each pair, several variables were selected, more specifically, 16 variables concerning the recipient, 17 concerning the donor, and finally 5 related to the surgery. Some of these variables such as etiology are encoded in a nominal scale (7 modalities), so for each modality, we generate a binary variable. In this way, the total number of variables is 55 (see Table 1 and the best models for CCR and MS in Supporting Text 1 and 2). Independent baseline results, comparisons between MADR-E and KCH, are depicted in Table 1 . As observed, data are significantly different, highlighting the main advantage of our models. We test ANNs in different transplant systems to get them to work properly according to the idiosyncrasies of the different populations.
ANN FOR KCH (3-MONTH GRAFT SURVIVAL MODEL)
The ANN models clearly improved the potential prediction of graft survival and graft nonsurvival at 3 months after the transplant. The CCR (AUROC 5 0.94) and MS (AUROC 5 0.94) models improved up to 10% with respect to the second-best score (BAR score; AUROC 5 0.84; Supporting Text 1; Fig. 1 ). As observed, the prediction capability is excellent and clearly better (increase > 11%) than in the previous original MADR-E model in which CCR and MS models predicted AUROC 5 0.81 and AUROC 5 0.82, respectively.
As observed in Supporting Texts 1 and 2, the variables with higher weight in the formulas of best models are pretransplant status, MELD at transplant, days on waiting list, etiology of liver disease from the recipient side; hypertension, cause of death, and AST level in the donor side; and cold ischemia time (CIT) from the surgical side. Therefore, we can assume that these characteristics tend to explain a majority (but not the whole working of the neural networks) of the variance in outcomes in most of the cases.
ANN FOR KCH (12-MONTH GRAFT SURVIVAL MODEL)
The impact of D-R matching on graft survival was also analyzed in the longterm setting (Supporting Text 2). One-year probability of graft (AUROC 5 0.78) and nongraft (AUROC 5 0.82) survivals were better predicted by ANNs compared with the best prediction achieved by other scores (BAR score; AUROC 5 0.71; Fig. 2 ).
SIMULATION OF D-R SELECTION USING THE RULE-BASED MODEL
For the application of the rule-based model, 5 random real recipients and 10 random potential donors were selected ( Table 2 ). The ANN calculated the highest probability of graft survival (CCR model) and the lowest probability of graft nonsurvival (MS model; Tables  3-5) . By combining both of them and using the rulebased system, a recipient was chosen for a specific donor, whose code can be seen in the last row of Tables 3-5. Table 3 shows an example with 10 possible donors and 5 recipients with MELD 23-27. When donor 1 is offered for transplantation, then recipient 1 is chosen in a clinical scenario where the allocation is MELD-driven. However, if we take into account our model, recipient 3 will be chosen, because there are no differences between recipients 1 and 3 in terms of probability of a functioning graft and because recipient 3 has the lowest probability of a nonfunctioning graft. A similar situation would happen for donors 3, 5, 6, 7, and 9. When donor 2 was selected, recipient 1 had a significantly higher probability of survival, and there NOTE: Each variable has a "numerical name" (x1 to x55), which is used to build the formulas of the mathematical models (see Supporting Text 1 and 2).
were no differences between all the recipients in the probability of nonsurvival, leading to the selection of recipient 1 as the best matching for that donor. For donor 4, all the recipients had equal survival probability, but recipient 3 had the lowest probability of nonsurvival. Therefore, this recipient was chosen. For donors 8 and 10, there were no significant differences between recipients 1 and 3 in terms of probability of survival and all of them had equal probability of nonsurvival; therefore, recipient 1 was chosen because of the higher MELD score (and thus, highest probability of death on waiting list). It should be remarked that the rule-based system respects the MELD allocation system as a whole, but it can select lower-MELD FIG. 1 . ANN model to predict 3-month graft survival developed using the KCH population for both training and testing and comparisons against other scores. Our CCR (CCRprobability of graft survival) and MS (MS-probability of nongraft survival) models were compared against MELD, D-MELD, DRI, SOFT, P-SOFT, and BAR scores.
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candidates when the probabilities of belonging to one class or another are more favorable. Two different models were developed to find out how ANN may work with high MELD scores. Accordingly, 2 models are depicted in Tables 4 and 5 in which it can be observed that MELD-driven allocation happens in some cases but not in others.
Discussion
The management of the waiting list for LT is not an easy task. The number of candidates is increasing, and it would be even higher if expanded indications were accepted for diseases such as colorectal liver metastases, flexible HCC criteria, or cholangiocarcinoma.
FIG. 2. ANN model to predict
1-year graft survival developed using the KCH population for both training and testing and comparisons against other scores. Our CCR (CCR-probability of graft survival) and MS (MS-probability of nongraft survival) models were compared against MELD, D-MELD, DRI, SOFT, P-SOFT, and BAR scores. Considering that patients with liver disease do not have the availability of a machine that could replace liver function, LT is a life-threatening procedure in which the scarcity of donors increases its complexity. The medical community needs a tool that could combine 3 unique features: objectivity (to avoid human subjectivity in the management of waiting list), optimization (to achieve highest posttransplant survival rates), and justice (to give the chance to be transplanted with advanced disease). Our findings confirm that an optimal D-R matching system would be an ANN-guided system trained, tested, and optimized for each health care system. Several systems have been proposed for D-R matching in LT. All of them have been built using multivariate models or statistical findings. Certainly, all of them NOTE: By randomly choosing 5 potential recipients with MELD score 23-27 and 10 random donors (depicted in Table 2 ), probability of survival (CCR) and nonsurvival (MS) were calculated. After that, and using the "rule-based system," a D-R pair is selected. have worked well and have highlighted the fact that donor and recipient, rather than running parallel, combine in a complex manner. However, it is difficult to believe that any of these models can be used robustly in different health care systems worldwide. The reasons for this include their heterogeneity, the different variables used, and that some of them are all-or-none systems in which only a small number of patients can be discriminated. For the sake of robustness and precision, these models should be updated when new data and different characteristics are available at the different transplant units. A further disadvantage is that access to transplantation may not be equally guaranteed in indications that do not meet "minimum listing criteria," such as recurrent encephalopathy or refractory ascites.
Our MADR-E worked well in the Spanish database grouping data from several centers. In this sense, the development of an ANN for KCH had excellent prediction capability, which was even better than the original MADR-E. The validation of our methodology as a tool for optimal D-R matching is supported by these findings. The authors would like to highlight the necessity of optimizing this model when new data (eg, from a different transplant unit) are available. The explanation for this would include that input variables NOTE: By randomly choosing 5 potential recipients with MELD score 34-40 and 10 random donors (depicted in Table 2 ), probability of survival (CCR) and nonsurvival (MS) were calculated. After that, and using the "rule-based system," a D-R pair is selected, which, in this case, is not the one with highest MELD score. The shaded background indicates statistically favorable values. Bold indicates selected values from all statistically significant. NOTE: By randomly choosing 5 potential recipients with MELD score 34-40 and 10 random donors (depicted in Table 2 ), probability of survival (CCR) and nonsurvival (MS) were calculated. After that, and using the "rule-based system," a D-R pair is selected, which, in this case, is allocated to the patient with the highest MELD score, unless the last donor should be allocated to recipient 2, as recipient 1 would have a poorer outcome. The potential utility of our model needs to be evaluated with a much larger population using large multinational databases. It is an attractive idea to think that it may be possible to find an ANN model for each LT program in every country. However, it should be possible for each transplant program to analyze their data by building their own decision support system model and generating specific D-R matching software. Note that ANNs could potentially work better if they could be developed using previously recorded data with no missing values. A potential area of research would be to prospectively build an ANN using hundreds of pretransplant variables and hundreds of posttransplant variables. Our group is now working on a potential further utilization of ANNs using more than 50,000 D-R patterns from the United Network for Organ Sharing database. Although attractive, the preliminary step of the finding from this external validation was mandatory prior to moving to larger databases.
Conventional regression analyses use historical data and try to fit them to some function. The drawback here is the difficulty of selecting an appropriate function capable of capturing all forms of data relationships as well as automatically modifying output in case of additional information because the performance of a candidate is influenced by a number of factors. This influence/relationship is not likely to be represented by a simple known regression model. An ANN, which mimics the human brain in problem solving, is a more general approach that can handle this type of problem by adapting itself, learning from every candidate, and modifying in every situation.
ANNs are complex tools. They can predict several important situations from which the life of human populations is decided. For example, during emergencies such as flood and drought seasons, reservoirs act as defense mechanisms to reduce the risk of flooding and to maintain water supply. During this period, decisions regarding water release is critical. (25) Another example is the prediction of water levels at Kainji Dam, which supplies water to Nigeria's largest hydropower generation station in which ANNs were built to generate a more efficient power supply. (26) All the models used hundreds of variables recorded daily for several years to build extremely accurate tools that have led to excellent prediction capabilities not reachable by the human mind and far from simplistic common statistical models. Nowadays, a huge number of processes are predicted worldwide, controlled and guided by ANNs. These models are all specifically designed for each individual process. For example, the ANN designed for forecast prediction in one place is not the same for another, or the one that controls the variables affecting flight status of 1 type of plane is not usable for another. The research field that our group has started has a very long way to go. Leaving the decision of who will get a graft and who will not, and thus, who will die, to software will not satisfy everyone. However, there are now many examples such as plague control, flight behavior, water level controls, dock openings, or weather forecasting that are ANN-controlled and may lead to the survival of thousands of people every day. The medical community has to explore the interface between human decisions and software-guided analysis, which is moving in favor of complex computational tools. A prospective trial may be the next step to make the transplant community consider these tools and to further apply the results of our analysis that shows that ANNs may accurately predict graft outcomes and guide D-R matching decisions in different health care systems.
